News | February 11, 2022
India’s first mRNA vaccine should be ready soon
It is being developed by Pune-based Gennova Biopharmaceuticals
It is being developed by Pune-based Gennova Biopharmaceuticals
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
This is the ninth Covid-19 vaccine approved in India
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
New role strengthens Quantori’s global leadership position in data science & digital IT
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Subscribe To Our Newsletter & Stay Updated
